{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:15:35Z","timestamp":1786979735901,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T00:00:00Z","timestamp":1337990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00198-012-2024-8","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T05:01:17Z","timestamp":1337922077000},"page":"245-252","source":"Crossref","is-referenced-by-count":60,"title":["Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients\u2014a nationwide register-based open cohort study"],"prefix":"10.1007","volume":"24","author":[{"given":"L.","family":"Bondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Eiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,26]]},"reference":[{"key":"2024_CR1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bone.2008.09.006","volume":"44","author":"AC Feldstein","year":"2009","unstructured":"Feldstein AC, Weycker D, Nichols GA, Oster G, Rosales G, Boardman DL, Perrin N (2009) Effectiveness of bisphosphonate therapy in a community setting. Bone 44:153\u2013159","journal-title":"Bone"},{"key":"2024_CR2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Col\u00f3n-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid and clinical fracture and mortality after hip fracture. N Engl J Med 357:1799\u20131809","journal-title":"N Engl J Med"},{"key":"2024_CR3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.310.6984.904","volume":"310","author":"CJ Todd","year":"1995","unstructured":"Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, Parker MJ, Payne BV, Rushton N (1995) Differences in mortality after fracture of hip: the East Anglian audit. BMJ 310:904\u2013908","journal-title":"BMJ"},{"key":"2024_CR4","first-page":"1538","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Increased mortality in patients with a hip fracture\u2014effect of pre-morbid and postfracture complications. Osteoporos Int 18:1538\u20131593","journal-title":"Osteoporos Int"},{"key":"2024_CR5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00198-003-1430-3","volume":"14","author":"MW Cree","year":"2003","unstructured":"Cree MW, Juby AG, Carriere KC (2003) Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int 14:722\u2013727","journal-title":"Osteoporos Int"},{"key":"2024_CR6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","volume":"152","author":"P Haentjens","year":"2010","unstructured":"Haentjens P, Magaziner J, Col\u00f3n-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380\u2013390","journal-title":"Ann Intern Med"},{"key":"2024_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ageing\/afp221","volume":"39","author":"PN Kannegaard","year":"2010","unstructured":"Kannegaard PN, Van Der Mark S, Eiken P, Abrahamsen B (2010) Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 39:203\u2013209","journal-title":"Age Ageing"},{"key":"2024_CR8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/bmj.38643.663843.55","volume":"331","author":"JJ Roche","year":"2005","unstructured":"Roche JJ, Wenn RT, Sahota O, Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374","journal-title":"BMJ"},{"key":"2024_CR9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2010-2730","volume":"96","author":"JR Center","year":"2011","unstructured":"Center JR, Bliuc D, Nguyen ND, Nguyen TV, Nguyen TV, Eisman JA (2011) Osteoporosis medication and reduced mortality risk in elderly women and men. J Clin Endocrinol Metab 96:1006\u20131014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024_CR10","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s00198-010-1444-6","volume":"22","author":"PN Sambrook","year":"2010","unstructured":"Sambrook PN, Cameron JS, Chen CJ, March LM, Simpson JM, Cumming RG, Seibel MJ (2010) Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Osteoporos Int 22:2551\u20132556","journal-title":"Osteoporos Int"},{"key":"2024_CR11","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2009-0852","volume":"95","author":"MJ Bolland","year":"2010","unstructured":"Bolland MJ, Grey AB, Gamble GD, Reid IR (2010) Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 95:1174\u20131181","journal-title":"J Clin Endocrinol Metab"},{"key":"2024_CR12","first-page":"623","volume":"180","author":"S Boufous","year":"2004","unstructured":"Boufous S, Finch CF, Lord SF (2004) Incidence of hip fracture in New South Wales: are our efforts having effect? MJA 180:623\u2013626","journal-title":"MJA"},{"key":"2024_CR13","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1359\/jbmr.091029","volume":"25","author":"ID Cameron","year":"2010","unstructured":"Cameron ID, Chen JS, March LM, Simpson JM, Cumming RG, Seibel MJ, Sambrook PN (2010) Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5\u00a0year study. J Bone Miner Res 25:866\u2013872","journal-title":"J Bone Miner Res"},{"key":"2024_CR14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/17453670903316835","volume":"80","author":"P Vestergaard","year":"2009","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2009) Loss of life years after a hip fracture: effects of age and sex. Acta Orthop 80:525\u2013530","journal-title":"Acta Orthop"},{"key":"2024_CR15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1359\/jbmr.081251","volume":"24","author":"P Szulc","year":"2009","unstructured":"Szulc P, Maurice C, Marchand F, Delmas PD (2009) Increased bone resorption is associated with higher mortality in community-dwelling men > 50\u00a0years of age: the MINOS study. J Bone Miner Res 24:1116\u20131124","journal-title":"J Bone Miner Res"},{"key":"2024_CR16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1359\/jbmr.060104","volume":"21","author":"PN Sambrook","year":"2006","unstructured":"Sambrook PN, Chen CJ, March L, Cameron ID, Cumming RG, Lord SR, Simpson JM, Seribel MJ (2006) High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res 21:549\u2013555","journal-title":"J Bone Miner Res"},{"key":"2024_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00262-008-0521-6","volume":"58","author":"D Santini","year":"2009","unstructured":"Santini D, Martini F, Fratto ME, Galluzzo S, Vincenzi B, Agrati C, Turchi F, Picentini P, Rocci L, Manavalan JS, Tonini G, Poccia F (2009) In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients. Cancer Immunol Immunother 58:31\u201338","journal-title":"Cancer Immunol Immunother"},{"key":"2024_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2249.2006.03216.x","volume":"146","author":"LD Carbone","year":"2006","unstructured":"Carbone LD, Warrington KJ, Barrow KD, Pugazhenthi M, Watsky MA, Somes G, Ingels J, Postlethwaite AE (2006) Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles. Clin Exp Immunol 146:371\u2013380, OK","journal-title":"Clin Exp Immunol"},{"key":"2024_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/TCRM.S19385","volume":"7","author":"L Fraser","year":"2011","unstructured":"Fraser L, Vogt KN, Adachi JD, Thabane L (2011) Fracture risk associated with continuation versus discontinuation of bisphophonates after 5\u00a0years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis. Ther Clin Risk Manag 7:157\u2013166","journal-title":"Ther Clin Risk Manag"},{"key":"2024_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/TCRM.S17513","volume":"7","author":"JD Adachi","year":"2011","unstructured":"Adachi JD, Josse RG, Graham R, Russell G (2011) If you don\u2019t take it\u2014it can\u2019t work: the consequences of not being treated or nonadherence to osteoporosis therapy. Ther Clin Risk Manag 7:181\u2013198","journal-title":"Ther Clin Risk Manag"},{"key":"2024_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MLR.0b013e318207ed9e","volume":"49","author":"JR Curtis","year":"2011","unstructured":"Curtis JR, Larson JJC, Delzell E, Brookhart MA, Cadarette SM, Chlebowski R, Suzanne J, Safford M, Solomon DH, LaCroix AZ (2011) Placebo adherence, clinical outcomes, and mortality in the Women\u2019s Health Initiative Randomized Hormone Therapy trials. Med Care 49:427\u2013435","journal-title":"Med Care"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-2024-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-2024-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T16:01:16Z","timestamp":1713974476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-2024-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,26]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2024"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-2024-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,26]]}}}